Bernard Tézé
Socio
Oficina(s) :
París
Contacto
Biografía
Bernard Tézé is a partner in the Corporate Department of DS Avocats in Paris.
He is involved in M&A, strategic alliances, partnerships, joint ventures and restructuring as well as private equity, LBO and Venture Capital, particularly in the regulated sectors (Healthcare Pharma-Biotech Medtech, Banking-Insurance and Fintech, Defence, NICT and e-commerce).
He is also involved in the ecosystem of start-ups, incubators, accelerators, family offices and venture funds.
Before joining DS in 2008, he was a Partner since 2001 at White&Case in Paris and before that Counsel at Clifford Chance in Paris.
He was also seconded for 4 years to a law firm in Japan where he returns very regularly in a professional capacity.
He has been involved in outbound acquisitions in China, Japan, Russia, Brazil and India.
Bernard graduated from HEC in 1985 and holds a Master's degree in Public and Private Law and a DESS (post-graduate diploma) in International Taxation.
He is Honorary President of the International Development Group of the HEC Association.
- Legal and tax adviser, then lawyer 1992
- HEC, 1982-1985
- Master’s (DESS) in International Tax Law, Paris Sud, 1986
- Master’s (maîtrise) in Public Law, Paris II, 1985 and Master’s (maîtrise) in Private Law, Paris II, 1986
- French
- English
- Le Point – Corporate Law (4 stars)
- IFLR 1000 – Corporate Law – Private Equity (Tier 5)
- IFLR 1000 – Corporate Law – M&A (Other Notable)
- Décideurs – Private Equity – Development capital transactions (Band 4 – Recommended)
- Décideurs – Private Equity – LBO lower mid & small-cap transactions (Band 4 – Recommended)
- Option Droit & Affaires – Mergers & Acquisitions where the majority of transactions are below €200 million (Band 2)
- Option Droit & Affaires – Development capital and LBOs with a majority of transactions under €50 million (Band 3)
- Option Droit & Affaires – Law firms specialized in innovation capital (Band 4)
- Option Droit & Affaires – Law firms specialized in fund structuring (Band 5)
- Leaders League – Healthcare, pharmaceuticals & biotech – Venture Capital (Highly recommended)
